GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male miceCarmelo Quarta, Timo D. Müller, Kerstin Stemmer et al.|Nature Metabolism|2022Cited by 38
[Efficacy of modified Roux-en-Y gastric bypass in the treatment of non-obese type 2 diabetes mellitus:one year follow-up].Bin Yang, L Wang, Hengli Lian et al.|PubMed|2012Cited by 2
GLP-1-mediated delivery of the PPAR𝛼/𝛾 dual-agonist Tesaglitazar improves obesity and glucose metabolism in miceCarmelo Quarta, Timo D. Müller, Kerstin Stemmer et al.|Research Square|2021Cited by 0